Trademarks owned by ACTAVIS HOLDCO US, INC. | Applied Marks - Trademark, Domain Name and Social Media Protection for Brands - /\\\ Applied Marks
owned ACTAVIS HOLDCO US, INC. owned ACTAVIS HOLDCO US, INC.

Trademarks owned by 'ACTAVIS HOLDCO US, INC.'

Summary of page content
2000-07-11
2531611
2002-01-22
US
W
Trademark Image
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    full line of pharmaceutical products
800
REGISTERED AND RENEWED
2012-01-30
2021-01-22
W ACTAVIS HOLDCO US, INC.
2018-03-16
US
Trademark Image
The mark consists of the word "ACTAVIS" below the letters "A" and "W", which appear in an intertwined fanciful lettering style that resembles a horizontal zig-zag line or a coil, which are both displayed in the color white. The word "ACTAVIS" and the letters "A" and "W" are centered within a rectangle displayed in the color gray.
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations; pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; pharmaceuticals and medicines affecting sensory organs; pharmaceuticals and medicines affecting the central nervous system; pharmaceuticals and medicines affecting urogenital organs; pharmaceuticals and medicines affecting circulatory systems; pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; antibiotics; antifungal preparations; pharmaceutical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of alzheimer's disease, dementia, aids-related dementia, neurological disorders, neurodegenerative disorders, and depression, antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; pharmaceutical preparations for the treatment of hypothyroidism; pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations; sterile antibiotic, anti-inflammatory ointments; ocular wetting solutions, artificial tears and formulations for the treatment of minor ocular inflammations and allergic conditions; pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body
732
THIRD EXTENSION - GRANTED
2020-11-05
2021-01-04
wear allied weather asia projects exhibitions publishing auto wildlife andersen angela william artists writers guild walker wireless clear choice credit
2020-07-28
US
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    medicinal preparation for the treatment of alcoholism
641
NON-FINAL ACTION - MAILED
2020-11-19
2020-11-19
ANTABUSE Actavis Holdco US, Inc.
2019-10-17
US
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations; pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; pharmaceuticals and medicines affecting the sensory organs; pharmaceuticals and medicines affecting the central nervous system; pharmaceuticals and medicines affecting the urogenital organs; pharmaceuticals and medicines affecting the circulatory systems; pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; antibiotics; antivirals and antiprotozoals; pharmaceutical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of alzheimer's disease, dementia, aids-related dementia, cns, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; pharmaceutical preparations for the treatment of hypothyroidism
602
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
2020-08-10
2020-08-10
RAYVEN Actavis Holdco US, Inc.
2018-03-16
US
Trademark Image
The mark consists of the word "ACTAVIS" below the letters "A" and "W", which appear in an intertwined fanciful lettering style that resembles a horizontal zig-zag line or a coil, which are both displayed in the color white. The word "ACTAVIS" and the letters "A" and "W" are centered within a rectangle displayed in the color gray.
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations; pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; pharmaceuticals and medicines affecting sensory organs; pharmaceuticals and medicines affecting the central nervous system; pharmaceuticals and medicines affecting urogenital organs; pharmaceuticals and medicines affecting circulatory systems; pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; antibiotics; antifungal preparations; pharmaceutical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of alzheimer's disease, dementia, aids-related dementia, neurological disorders, neurodegenerative disorders, and depression, antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; pharmaceutical preparations for the treatment of hypothyroidism; pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations; sterile antibiotic, anti-inflammatory ointments; ocular wetting solutions, artificial tears and formulations for the treatment of minor ocular inflammations and allergic conditions; pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body
732
THIRD EXTENSION - GRANTED
2020-11-05
2021-01-04
wear allied weather asia projects exhibitions publishing auto wildlife andersen angela william artists writers guild walker wireless clear choice credit
2016-09-16
US
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations; pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; pharmaceuticals and medicines affecting sensory organs; pharmaceuticals and medicines affecting the central nervous system; pharmaceuticals and medicines affecting urogenital organs; pharmaceuticals and medicines affecting circulatory systems; pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure diseases and disorders; pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; antibiotics; antifungal preparations; antivirals and antiprotozoals; pharmaceutical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of alzheimer's disease, dementia, aids-related dementia, cns, neurological disorders, neurodegenerative disorders, and depression; pharmaceuticals, namely, neuroprotective agents; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; pharmaceutical preparations for the treatment of hypothyroidism; pharmaceutical preparations for skin care used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatories, anti-infectives, anti-glaucoma eye drops and decongestant formulations; sterile ointments for medical use; ocular wetting solutions, artificial tears and formulations pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, skin rejuvenators, rehydrating creams, and lotions for the face and body
606
ABANDONED - NO STATEMENT OF USE FILED
2020-03-31
2020-06-03
DAFIDA ACTAVIS HOLDCO US, INC.
2016-09-16
5351657
2017-12-05
US
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    oral contraceptive preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy
700
REGISTERED
2017-12-05
2020-05-31
LAYOLIS ACTAVIS HOLDCO US, INC.
2016-10-26
US
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for the treatment and prevention of digestive tract and gastrointestinal diseases and disorders and acid blockers
606
ABANDONED - NO STATEMENT OF USE FILED
2018-12-17
2020-05-31
day through health living natural body relief 200 prilosec hours had center pill honey fast prevent acid blocker burning desire
2013-10-22
4783581
2015-07-28
US
Trademark Image
The mark consists of the word "ACTAVIS" below the letters "a" and "w", which appear in an intertwined fanciful lettering style that resembles a horizontal zig-zag line or a coil, which are both displayed in the color white. The word "ACTAVIS" and the letters "a" and "w" are centered within a rectangle displayed in the color gray.
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for the treatment of dermatological diseases and disorders, pharmaceutical preparations for skin care, anti-infectives; antiparasitic preparations and substances and antineoplastic agents, all of the foregoing specifically excluding tissue plasminogen activators
700
REGISTERED
2015-07-28
2020-07-28
wear allied weather asia projects exhibitions publishing auto wildlife andersen angela william artists writers guild walker wireless clear choice credit
2016-01-27
US
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations; pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; pharmaceuticals and medicines affecting the sensory organs; pharmaceuticals and medicines affecting the central nervous system; pharmaceuticals and medicines affecting the urogenital organs; pharmaceuticals and medicines affecting the circulatory systems; pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; antibiotics; antivirals and antiprotozoals; pharmaceutical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of alzheimer's disease, dementia, aids-related dementia, cns, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; pharmaceutical preparations for the treatment of hypothyroidism
  • 10
    Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
    contraceptive device, namely, an intrauterine device
606
ABANDONED - NO STATEMENT OF USE FILED
2019-09-23
2020-05-31
RAYVEN ACTAVIS HOLDCO US, INC.
2016-01-27
US
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations; pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; pharmaceuticals and medicines affecting the sensory organs; pharmaceuticals and medicines affecting the central nervous system; pharmaceuticals and medicines affecting the urogenital organs; pharmaceuticals and medicines affecting the circulatory systems; pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; antibiotics; antifungal preparations; antivirals and antiprotozoals; pharmaceutical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of alzheimer's disease, dementia, aids-related dementia, cns, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; pharmaceutical preparations for the treatment of hypothyroidism
  • 10
    Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
    contraceptive device, namely, an intrauterine device
606
ABANDONED - NO STATEMENT OF USE FILED
2019-03-25
2020-05-31
SELSTRA ACTAVIS HOLDCO US, INC.
2015-02-23
5214478
2017-05-30
US
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    oral contraceptive preparations
700
REGISTERED
2017-05-30
2020-05-31
RAJANI ACTAVIS HOLDCO US, INC.
2015-04-01
US
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations; pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; pharmaceuticals and medicines affecting sensory organs; pharmaceuticals and medicines affecting the central nervous system; pharmaceuticals and medicines affecting urogenital organs; pharmaceuticals and medicines affecting circulatory systems; pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; antibiotics; antifungal preparations; antivirals and antiprotozoals; pharmaceutical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of alzheimer's disease, dementia, aids-related dementia, cns, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; pharmaceutical preparations for the treatment of hypothyroidism
606
ABANDONED - NO STATEMENT OF USE FILED
2018-11-05
2020-05-31
CASSIPA ACTAVIS HOLDCO US, INC.
2014-06-20
US
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    contraceptive preparations; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations; pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; pharmaceuticals and medicines for the sensory organs; pharmaceuticals and medicines for the central nervous system; pharmaceuticals and medicines for the urogenital organs; pharmaceuticals and medicines for the circulatory systems; pharmaceuticals and medicines for the treatment of cardiovascular diseases and blood pressure; pharmaceuticals preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; antibiotics; antimicrobial preparations for inhibiting microbiological decomposition in pharmaceuticals
606
ABANDONED - NO STATEMENT OF USE FILED
2018-02-26
2020-05-31
BANETTE ACTAVIS HOLDCO US, INC.
2013-10-22
US
Trademark Image
The mark consists of the word "ACTAVIS" below the letters "a" and "w", which appear in an intertwined fanciful lettering style that resembles a horizontal zig-zag line or a coil, which are both displayed in the color white. The word "ACTAVIS" and the letters "a" and "w" are centered within a rectangle displayed in the color gray.
  • 3
    Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
    cosmetic soaps, antibacterial skin soaps, bath soaps, and cream soaps; perfumery; essential oils; cosmetics; skin and hair care preparations; cosmetic preparations for skin care; cosmetic preparations for body care; cosmetic preparations for bath and shower; cosmetic creams, lotions, ointments, gels, skin fresheners, toners, cleansers and peels for skin care; cosmetic preparations for the hair and scalp; non-medicated moisturizing preparations for the skin; non-medicated skin care creams, lotions, ointments, gels, skin fresheners, toners, cleansers and peels; non-medicated hair shampoos, hair lotions and hair conditioners; dentifrices, non-medicated dental rinses, mouth rinses and mouth washes; dentifrices in the form of chewing gum, non-medicated dental lozenges and tablets; breath fresheners; non-medicated mouth sprays for freshening breath and to treat dry mouth; cosmetic preparations for the care of the mouth and teeth, anti-cavity dental rinses, non-medicated mouth rinses and mouth washes
606
ABANDONED - NO STATEMENT OF USE FILED
2018-02-12
2020-05-31
wear allied weather asia projects exhibitions publishing auto wildlife andersen angela william artists writers guild walker wireless clear choice credit
2013-10-22
US
Trademark Image
The mark consists of the word "ACTAVIS" below the letters "a" and "w", which appear in an intertwined fanciful lettering style that resembles a horizontal zig-zag line or a coil, which are both displayed in the color white. The word "ACTAVIS" and the letters "a" and "w" are centered within a rectangle displayed in the color gray.
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations and substances for the prevention and treatment of alimentary tract and metabolic diseases and disorders, dermatological diseases and disorders, genito-urinary and sexual diseases and disorders, musculo-skeletal system diseases and disorders, nervous system diseases and disorders, respiratory system diseases and disorders, cardio-vascular diseases and disorders, gastro-intestinal diseases and disorders, sensory organ diseases and disorders; systemic hormonal pharmaceutical preparations and substances; pharmaceuticals, namely, anti-infectives; pharmaceutical preparations, namely, antineoplastic and immunomodulating agents; antiparasitic preparations and substances; contraceptive preparations; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations; pharmaceutical preparations and substances for the treatment of premenstrual syndrome, post natal depression, fluctuating hormone levels; pharmaceutical preparations and substances for infertility disorders; pharmaceutical preparations and substances for in vitro fertilization (ivf); pharmaceutical preparations in the nature of medicated dental rinses, mouth rinses, mouthwashes, dental lozenges, dental tablets and medicated chewing gum; dental wax; pharmaceutical preparations in the nature of pregnancy test kits, ovulation test kits and in-vitro ovulation prediction test kits all for home use; pharmaceutical preparations in the nature of diagnostic test kits for home use for detecting urinary tract infections, for detecting menopause, for detecting vaginal ph balances and for detecting sexually-transmitted diseases; pharmaceutical preparations for skin care, all of the foregoing specifically excluding tissue plasminogen activators
606
ABANDONED - NO STATEMENT OF USE FILED
2018-04-23
2020-05-31
wear allied weather asia projects exhibitions publishing auto wildlife andersen angela william artists writers guild walker wireless clear choice credit
2013-10-22
US
Trademark Image
The mark consists of the word "ACTAVIS" below the letters "a" and "w", which appear in an intertwined fanciful lettering style that resembles a horizontal zig-zag line or a coil, which are both displayed in the color white. The word "ACTAVIS" and the letters "a" and "w" are centered within a rectangle displayed in the color gray.
  • 10
    Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
    surgical, medical, dental and veterinary apparatus and instruments, namely, diagnostic test kits principally composed of medical diagnostic meters that measure conditions of the cardio-vascular and immune systems; medical diagnostic instruments for the analysis of body fluids
606
ABANDONED - NO STATEMENT OF USE FILED
2017-09-11
2020-05-31
wear allied weather asia projects exhibitions publishing auto wildlife andersen angela william artists writers guild walker wireless clear choice credit
2013-06-05
4694086
2015-03-03
US
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    generic pharmaceuticals, namely, preparations and substances for the prevention and treatment of alimentary tract and metabolic diseases and disorders, dermatological diseases and disorders, genito-urinary and sexual diseases and disorders, musculo-skeletal system diseases and disorders, nervous system diseases and disorders, respiratory system diseases and disorders, cardio-vascular diseases and disorders, specifically excluding tissue plasminogen activators, sensory organ diseases and disorders, systemic hormonal pharmaceutical preparations and substances, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, antiparasitic preparations and substances; all the foregoing specifically excluding tissue plasminogen activators
700
REGISTERED
2015-03-03
2020-05-31
ACTAVIS ACTAVIS HOLDCO US, INC.
2013-08-12
US
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    contraceptives; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations
606
ABANDONED - NO STATEMENT OF USE FILED
2017-02-13
2020-05-31
advantage system management design wyatt chalin dietz elementary value montgomery tom dr john associates capital baby barnes fine teas color
2012-11-07
5586410
2018-10-16
US
Trademark Image
The mark consists of the word "ACTAVIS" below the letters "a" and "w", which appear in an intertwined, fanciful lettering style that resembles a horizontal zig-zag line or a coil.
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for the treatment of alimentary tract diseases and disorders, musculo-skeletal system diseases and disorders, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic, antiparasitic preparations and substances; contraceptives; hormone replacement therapy preparations; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations and substances for the treatment of fluctuating hormone levels
700
REGISTERED
2018-10-16
2020-05-31
ACTAVIS ACTAVIS HOLDCO US, INC.
First 1 2 3 Last  1 of 3
NEED HELP? Chat with us online

Copyright 2008 - 2024 Applied Marks Pty Ltd (ACN 134 698 249). All rights reserved. Terms of Service, Privacy Policy and Acceptable Use Policy.